Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
GenomeUp logo — GenomeUp is medical software that uses AI to create a detail...

GenomeUp

GenomeUp is medical software that uses AI to create a detailed clinical report for doctors.

Founded 2017 Italy Italy 2-10 employees

General Information

Company Name GenomeUp
Founded Year 2017
Location Italy Italy
Employees 2-10
Social

Get notified when GenomeUp moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About GenomeUp

GenomeUp is a medical software startup based in Italy, founded in 2017. The company's slogan, "GenomeUp is medical software that uses AI to create a detailed clinical report for doctors," encapsulates its core offering. GenomeUp provides a SaaS platform for precision medicine, enabling healthcare professionals to harness the power of Artificial Intelligence (AI) in analyzing patients' genetic data. The platform offers in-depth clinical reports on genetic factors affecting patients' conditions, including the severity of mutations and personalized treatment options. Notably, GenomeUp leverages the world's most comprehensive biomedical database, PubMed, to provide accurate insights. The company's focus on harnessing AI for personalized medicine aligns with the growing demand for innovative healthcare solutions. However, specific details about investment history and current industries are not available. GenomeUp's potential for disrupting the medical software landscape and addressing the need for personalized treatment options presents an intriguing opportunity for venture capital investment. As the healthcare industry increasingly leans towards precision medicine, GenomeUp's utilization of AI in clinical genetic analysis positions it as a promising player in the evolving healthcare technology space.

Taxonomy: medical software, precision medicine, genetic analysis, clinical reports, biomedical database, PubMed, genomic data analysis, personalized medicine, healthcare professionals, genetic factors, treatment options

No funding data available for GenomeUp yet.

Get notified when GenomeUp raises funding

GenomeUp Alternatives & Competitors

GenomeUp vs
NGeneR
NGeneR Denmark

Make every day progress for better health.

2-10 employees
Biotechnology, Health Care
GenomeUp vs
CRI Genetics
CRI Genetics United States

Our mission at CRI Genetics is to unlock complex information in your genetics to educate and empower...

39 employees
Biotechnology, Life Sciences
GenomeUp vs
Future DNA
Future DNA Turkey

A concise overview of genetic data analysis.

Life Sciences

FAQ About GenomeUp

GenomeUp is medical software that uses AI to create a detailed clinical report for doctors.
GenomeUp was founded in 2017.
GenomeUp is headquartered in Italy.
GenomeUp has approximately 2-10 employees.
Top alternatives and competitors to GenomeUp include NGeneR, CRI Genetics, Future DNA, CENTOGENE, tellmeGen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GenomeUp and NGeneR are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors GenomeUp and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy